For four decades, science has learned to silence HIV without learning to erase it — the virus persists, hidden in the body's own cells, waiting. Now amfAR, the Foundation for AIDS Research, is committing $1.92 million to four research teams whose approaches borrow from mRNA vaccine technology, cancer immunotherapy, and precision immunology to confront that hidden reservoir directly. The funding arrives at a moment of paradox: scientific tools have never been more sophisticated, yet traditional research dollars are growing scarcer even as global infection rates climb. What these four studies sh
amfAR Funds Four Innovative HIV Cure Studies With $1.92M Investment
Over 40 million people globally live with HIV, with increasing infection rates in Eastern Europe, Central Asia, the Pacific, and major U.S. cities.